SUMMARY Altogether 54 children exposed prenatally to maternal cytomegalovirus (CMV) infection were followed up in a prospective study. Nine had congenital infection with CMV and 37 escaped congenital infection; in 8 congenital CMV could not be confirmed. The birthweight of children with congenital CMV was significantly lower than that of both controls and those who escaped congenital infection. Intrauterine infection was not clinically suspected in any of the children with congenital CMV, although two had head circumferences less than the third centile. Subsequently one child with congenital CMV developed marked psychomotor retardation, and one, in whom congenital CMV was not confirmed, showed mild developmental delay. Speech and language ability was significantly impaired in children with congenital CMV compared with controls and those who escaped congenital infection, suggesting that subtle damage may have occurred.
Cytomegalovirus (CMV) is the most common viral infection known to be transmitted in utero.1 Although most infants with congenital CMV infection are normal at birth, with fewer than 5%
showing neurological signs in the neonatal period, a further 1020% may develop neurological sequelae such as mental handicap or sensorineural deafness in the first years of life.2 5 Screening of mothers to identify primary CMV infection in pregnancy has been advocated to reduce the number of infants handicapped by CMV.6 There are, however, inadequate data as yet on which to recommend termination of pregnancy. In this study we attempted to estimate the incidence of intrauterine transmission of CMV after primary maternal infection at different stages of pregnancy, and to determine whether the adverse sequelae of congenital CMV are related to the stage of pregnancy at which infection occurs. In addition to following up those children with congenital infection we also followed up 54 pregnancies resulted in the birth of live infants and are the subject of the present paper.
In 46 of the 54 cases of primary maternal infections appropriate specimens were collected from the neonates to diagnose or exclude congenital infection. Nine of the 46 (20%) were congenitally infected (Table 1 ). In a further 8 infants no cord blood or early urine samples were available so it was not possible to establish whether intrauterine transmission had occurred. (Fig. 2) . The mean scores for the expressive scale were +0-27 for controls and +0 38 for those not infected with CMV. The mean of-1 08 for those with congenital CMV was significantly below both groups (P<0.05 in both cases). When the child with psychomotor delay is excluded from this analysis the difference is still significant when compared with those who escaped congenital infection (P<0.05) but not when compared with controls. A significant difference was also found in the verbal comprehension score in both comparisons (P <0 05) even excluding the child with psychomotor delay.
Discussion
Maternal CMV infection has been shown to be associated with high fetal wastage8; placental infection without transmission to the fetus has also been reported.12 Follow up of the infants who escaped congenital infection showed that their development had been normal. We conclude, therefore, that maternal infection that is not transmitted to the fetus has no harmful effects on that child's subsequent neurological development. The overall incidence of intrauterine transmission in this study was 20 %. This contrasts with the findings of other workers who found a transmission rate in London of 45 %,13 in Sweden of 43 %,14 and in Scotland of 38 %.15 All these previous studies used seroconversion to identify maternal infections and so were unable to detect primary infections before the first antenatal visit. We used a combination of seroconversion and detection of IgM antibody by solid phase radioimmunoassay and found that, though the incidence of CMV infection is the same throughout pregnancy, the incidence of intrauterine transmission in early pregnancy was 20% compared with 40% in late pregnancy. The rate after seroconversion in this study was 29 % but in the IgM positive group it was only 8 %. This may partly account for the differences in overall incidence of transmission between previous studies and our own. This trend of increased intrauterine transmission towards the end of pregnancy has also been reported for toxoplasmosis16 and rubella.17
In contradistinction to both toxoplasmosis and rubella, early intrauterine infection with CMV does not seem to be more damaging to the fetus. In the present study the two infants with congenital infection whose mothers developed primary CMV infection in the first trimester were both normal at 6 years and 3 months respectively. The only congenitally infected child in this study to show delay in psychomotor development was exposed to maternal infection at around 33 weeks' gestation. Overall, therefore, we can provide no evidence that early intrauterine infection is more likely than late infection to result in future handicap.
None of the infants in this study was clinically suspected of having congenital CMV infection. Although mean birthweight of congenitally infected infants was significantly lower than controls, only one was small for gestational age. The child, who subsequently developed psychomotor delay, had a birthweight of 3700 g and so did not give rise to concern at birth. Starr 20 but neither of the children in the present study who had a head circumference below the third centile showed any neurological defect at birth and both showed normal intellectual development at ages 3 and 4 years respectively. The older child's head circumference at follow up was in the normal range, but the younger one, who was also small for gestational age remained small with height and weight on the tenth centile and head circumference on the third centile.
It is possible that congenital CMV infection may cause more subtle defects that are not apparent in routine physical examination.3 20 Evaluations using the Reynell Development Language Scale, a precise measurement of a child's speech and language ability, suggests that this may be so. Results in congenitally infected children showed a definite trend towards lower values even when the one child with known psychomotor delay was excluded. As the number of congenitally infected children was small, this observation needs cautious interpretation. The Reynell assessments should be repeated at 5 years of age and we will then be able to determine whether these interesting preliminary observations become more or less apparent.
None of the 9 congenitally infected children had sensorineural deafness, although this has been reported to develop in 8-50 % of infected children.2 5
It is essential to follow all infected children to 5 years of age because, as in rubella, CMV deafness may be progressive.2' One unexpected finding was the high incidence of secretory otitis media in children who escaped intrauterine transmission despite maternal infection. This may be caused by CMV infection acquired either perinatally or in the postnatal period, ages at which upper respiratory infections and pneumonitis have been associated with CMV.22 23 The findings in this study suggest that screening in pregnancy for primary CMV infection is of limited value. We identified primary maternal infection in 54 women; in 30, in whose babies it was possible to confirm or exclude congenital infection, it developed before the legal limit for termination of pregnancy. Only two of these infants were congenitally infected. One infant not infected died soon after birth, but the other 29 were progressing normatly at follow up. This suggests that termination of early infection is not warranted. Furthermore, reactivation of latent maternal infection, which may be responsible for at least 1500 of cases of congenital CMV in this country,24 may not be identified by the serological methods currently available.
Screening for CMV infection in pregnancy may be useful in alerting paediatricians to infants with possible congenital infection with CMV but specimens of urine must be obtained from these babies within three weeks of birth if such a diagnosis is to be confirmed.25 After this period children who acquire CMV perinatally will excrete CMV and distinction between congenital and acquired infection is not possible. This is illustrated by 8 children in this study from whom we were unable to collect samples for virus culture within the first three weeks; they were therefore excluded. One of two subsequently shown to be culture positive at 5 and 7 months respectively developed neurological impairment. This child was delivered at another hospital at 30 weeks' gestation, the mother having developed CMV infection late in the second trimester. The infant was moderately jaundiced (maximum bilirubin concentration 270 ,umol/l (16 mg/100 ml)) and treated with phototherapy. Subsequently he developed mild psychomotor delay and retrolental fibroplasia. This suggests that congenital infection may have occurred, but, as is often the case in clinical practice, by the time these symptoms were present definitive, retrospective diagnosis of congenital CMV was not possible.
We conclude that the model of intrauterine infection based on rubella is not appropriate for CMV and that screening in pregnancy cannot be advocated in routine practice. At present it is not possible to judge whether screening neonates for congenital CMV is warranted, but large prospective British studies are in progress to assess the value of this procedure.
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